Interpace Biosciences Inc Quick Ratio (PDII) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Interpace Biosciences Inc   (PDII)

Interpace Biosciences Inc 's Quick Ratio

PDII's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.54 below Interpace Biosciences Inc average.

Within Medical Equipment & Supplies industry 145 other companies have achieved higher Quick Ratio than Interpace Biosciences Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1545 to 2362.

Explain Quick Ratio?
How much Cash & cash equivalents PDII´s has?
What are PDII´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PDII Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change -30.75 % -54.34 % -51.93 % -68.33 % -62.43 %
Y / Y Cash & cash equivalent Change 435.46 % 121.32 % 71.46 % 1.64 % 0.4 %
Quick Ratio MRQ 0.54 0.67 0.49 0.24 0.07
PDII's Total Ranking # 2362 # 1545 # 2215 # 3018 # 2071
Seq. Current Liabilities Change 24.96 % -22.36 % -14.16 % -16.84 % -17.62 %
Seq. Cash & cash equivalent Change 1.55 % 5.67 % 76.04 % 183.47 % -58.03 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 146
Healthcare Sector # 727
Overall Market # 2362


Quick Ratio Statistics
High Average Low
2.19 0.73 0.04
(Jun 30 2011)   (Dec 31 2016)




Financial Statements
Interpace Biosciences Inc 's Current Liabilities $ 5 Millions Visit PDII's Balance sheet
Interpace Biosciences Inc 's Cash & cash equivalent $ 3 Millions Visit PDII's Balance sheet
Source of PDII's Sales Visit PDII's Sales by Geography


Cumulative Interpace Biosciences Inc 's Quick Ratio

PDII's Quick Ratio for the trailling 12 Months

PDII Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -55.85 % -61.19 % -54.52 % -50.89 % -24.02 %
Y / Y Cash & cash equivalent TTM Growth 103.18 % 55.3 % -8.86 % -44.19 % -61.5 %
Quick Ratio TTM 0.46 0.32 0.21 0.14 0.1
Total Ranking TTM # 4049 # 4087 # 3157 # 3337 # 3211
Seq. Current Liabilities TTM Growth -9.92 % -17.55 % -17.02 % -28.36 % -20.81 %
Seq. Cash & cash equivalent TTM Growth 30.89 % 25.79 % 22.78 % 0.5 % 0.04 %

Quick ratio ranking by company, industry and sector >> Back to PDII Financial Strength Comparisons >> Go to Compare PDII Quick Ratio to its Competitors

On the trailing twelve months basis PDII Cash & cash equivalent more than doubled by 435.46 % in Q2 2026 year on year, while Current Liabilities grew to $5 millions, this led to increase in in Interpace Biosciences Inc 's Quick Ratio to 0.46, Quick Ratio remained below PDII average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Interpace Biosciences Inc . While Quick Ratio overall ranking has improved so far to 4049, from total ranking during the twelve months ending first quarter 2026 at 4087.

Explain Quick Ratio?
How much Cash & cash equivalents PDII´s has?
What are PDII´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 903
Within the Market # 4049


trailing twelve months Quick Ratio Statistics
High Average Low
1.57 0.65 0.13
(Jun 30 2018)   (Dec 31 2016)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Precision Optics Corporation Inc   1.11 $ 9.841  Millions$ 8.828  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions
Lifeward ltd   0.85 $ 9.448  Millions$ 11.159  Millions
Qhslab Inc   0.84 $ 0.317  Millions$ 0.376  Millions

Date modified: 2026-08-12T20:40:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.